Detalles de la búsqueda
1.
Genomics to select treatment for patients with metastatic breast cancer.
Nature
; 610(7931): 343-348, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36071165
2.
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors.
Oncologist
; 28(3): 258-267, 2023 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36571770
3.
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours.
Br J Clin Pharmacol
; 89(3): 1046-1055, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36131603
4.
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial.
Lancet Oncol
; 23(8): 1044-1054, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35835135
5.
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group.
Int J Cancer
; 150(5): 825-836, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34611903
6.
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group.
Int J Cancer
; 150(4): 645-653, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34562271
7.
Real-World Experience of Efficacy and Safety of Trabectedin in Patients with Soft Tissue Sarcoma: A Bicentric Retrospective Analysis.
Oncology
; 100(12): 633-644, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36283345
8.
Risk factors for biliary stent infections in malignant biliary obstruction secondary to unresectable malignancies.
Support Care Cancer
; 30(8): 6937-6946, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35543817
9.
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Invest New Drugs
; 39(6): 1641-1648, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34322775
10.
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study.
Ann Surg Oncol
; 27(5): 1693-1699, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31773519
11.
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).
BMC Cancer
; 20(1): 117, 2020 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32050939
12.
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
Br J Clin Pharmacol
; 86(9): 1807-1818, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32227355
13.
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
AJR Am J Roentgenol
; 215(6): 1539-1548, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32991215
14.
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113).
Int J Gynecol Cancer
; 30(10): 1633-1637, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32546554
15.
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
; 20(1): 120-133, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477937
16.
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Lancet Oncol
; 20(9): 1263-1272, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31331699
17.
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Lancet Oncol
; 20(8): 1109-1123, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31301962
18.
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years.
Int J Cancer
; 145(8): 2135-2143, 2019 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30924137
19.
Health-related quality of life as an endpoint in oncology phase I trials: a systematic review.
BMC Cancer
; 19(1): 361, 2019 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30991990
20.
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO).
Oncologist
; 23(8): 948-955, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934413